figshare
Browse
40164_2017_74_MOESM4_ESM.docx (898.99 kB)

MOESM4 of Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

Download (898.99 kB)
journal contribution
posted on 2017-05-18, 05:00 authored by Virginie Nägele, Andrea Kratzer, Gerhard Zugmaier, Chris Holland, Youssef Hijazi, Max Topp, Nicola Gökbuget, Patrick Baeuerle, Peter Kufer, Andreas Wolf, Matthias Klinger
Additional file 4. Available patient numbers (N) for analysis of distribution profiles of CD8+ and CD4+ T cells and subsets in Fig. 4.

Funding

Amgen Research (Munich) GmbH

History